entertainment -WSS

entertainment

author：comprehensive 2025-10-02 23:59:47 - browse：655

a person wearing blue dress conducts a finger prick test on another person in a home setting — coverage from STAT — Adobe

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. Their products aren’t cheap, but in the long term, they pitch to health plans and employers that these digital tools will help cut health care costs by preventing serious complications like amputation and kidney failure.

A systematic review by the Peterson Health Technology Institute found, though, that digital tools used to manage diabetes with the help of finger-stick blood glucose readings don’t result in clinically meaningful improvements over standard care. As a result, they don’t reduce health care spending — they drive it up.

“Most of the solutions in this category do not deliver clinical benefits that justify their cost,” Caroline Pearson, executive director of the institute, told STAT. Despite finding that some populations may benefit, the report concludes that current evidence doesn’t support broader adoption for most products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： 2 million sign

explore

hotspot

WSS

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Israel withdraws forces after 2

5 shark bites reported on Long Island as officials deploy surveillance drones

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

focus

entertainment

entertainment

Psychedelics group wrestles with new pharma identity

340B reform proposal comes out of Senate working group

How to save PrEP access — and even expand it

China dismisses criticism of top diplomat's comments appearing to push for race

Apple is now the first public company to be valued at $3 trillion

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Trump demands the U.S. pay no more for drugs than other countries … again

Texas Medical Board asked to define abortion emergency exception

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Texas Medical Board asked to define abortion emergency exception

explore

Problems with a popular proposal to regulate AI in health care

5 shark bites reported on Long Island as officials deploy surveillance drones

Padmanee Sharma of MD Anderson at center of lawsuit over credit

EU moves toward latest gene techniques in food production to counter climate change, shortages

Readout Newsletter: Amgen, Regeneron, BGI Group and more

2 million sign

explore

hotspot

hotspot

leisure time